ARCHIVES

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

This article is from The Cancer Letter archive.

Vol. 31 No. 18 | May 6, 2005

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

October 15, 2004

Support Available For Studies Abroad

August 12, 1983

Satcher Calls For Wider Use Of Smoking Prevention Efforts.

September 29, 2000

Biomedical Panel To Hear Public At Sept. Meeting

July 11, 1975

Obituaries: Karen Johnson of NCI; Merrill Egorin of UPCI

September 17, 2010

CDC: About 8 Million Women Skipped Cervical Cancer Screening in the Past 5 Years

November 14, 2014